
Air Liquide Healthcare is engaged alongside patients, healthcare professionals and hospitals to make the healthcare system efficient and virtuous for all.
As a major world player in home healthcare, an expert in chronic disease follow-up at home, and a supplier of medical gases for hospitals, the 16,500 men and women it employs support 1.7 million patients at home and 15,000 hospitals and clinics, in more than 35 countries.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca & Air Liquide Healthcare support the Chair through grants
that do not interfere with the Chair’s teaching and scientific activities.